Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail

Zydus Cadila on Thursday announced that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19. ....

 

Full Story

DCGI Okays Study On Mixing Covaxin & Covishield, Trial In Vellore

The Drugs Controller General of India (DCGI) has given the approval to conduct a study on mixing of Covishield and Covaxin vaccines. The step has been taken to boost the mass vaccination drive against the coronavirus across the nation. ....

 

Full Story

COVID: Biological E Gets DCGI Nod To Conduct Phase 2/3 Trials On Children

The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children. The trial will be on children between 5 and 18 years of age with certain conditions. ....

 

Full Story

Covid-19: DCGI Approves Phase II-III Clinical Trials Of Covaxin On Children Aged 2 To 18 Years

The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry said on Thursday. ....

 

Full Story